MCA DocumentMCA-F-501/11 (header); MCA-T-501/11 (footer), version 2 – 24 January 2025
Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.
Declaration of Investigator is published by Medicines Control Agency, The Gambia. This document is identified by its title; no separate official document code is recorded.
- Instrument
- Document
- Full name
- MCA-F-501/11 (header); MCA-T-501/11 (footer), version 2 – 24 January 2025
- Category
- Clinical Trials
- Source publication
- English
- Readable HTML
- 1 language version
- Published
- —
- Effective
- —
Open a language version
Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.
Declaration of Investigator
Complete one-page investigator declaration, version 2 dated 24 January 2025. It includes investigator role choices and declarations about trial duties, conflicts of interest and previous GCP or ethical closures. The source identifies the form as MCA-F-501/11 in the header and MCA-T-501/11 in the footer; this discrepancy is retained without choosing or inventing a corrected official code. Later revisions and current applicability remain unverified.
This document is identified by its title; no separate official document code is recorded. Always confirm the current consolidated text and transition provisions with the official source before filing.